Referred to the House Committee on Energy and Commerce.
The bill directs the Department of Health and Human Services and NIH to expand research, public health promotion, training, awareness, and care coordination for perimenopause, menopause, and mid-life women’s health. It creates new grant programs, Centers of Excellence, data reporting (a dashboard), occupational health research, and annual reporting requirements, and authorizes multi-year appropriations for specified programs.
Left emphasizes health equity and research funding; right emphasizes federal spending and scope limits.
Relative to its intended legislative type, this bill establishes a coherent statutory framework to expand federal activity on menopause care and mid-life women’s health by amending the Public Health Service Act, assigning responsibilities to NIH and HHS, authorizing multi-year funding, and adding reporting and evaluation requirements.
The bill directs the Department of Health and Human Services and NIH to expand research, public health promotion, training, awareness, and care coordination for perimenopause, menopause, and mid-life women’s health.
It creates new grant programs, Centers of Excellence, data reporting (a dashboard), occupational health research, and annual reporting requirements, and authorizes multi-year appropriations for specified programs.
Narrow, technocratic, and grant-focused measures with modest funding generally fare well, but enactment depends on appropriations and legislative priorities.
Relative to its intended legislative type, this bill establishes a coherent statutory framework to expand federal activity on menopause care and mid-life women’s health by amending the Public Health Service Act, assigning responsibilities to NIH and HHS, authorizing multi-year funding, and adding reporting and evaluation requirements.
Left emphasizes health equity and research funding; right emphasizes federal spending and scope limits.
These are examples from the analysis, not a ranked list of the most-affected groups.
Left emphasizes health equity and research funding; right emphasizes federal spending and scope limits.
Generally strongly supportive: sees the bill as filling long-standing research and care gaps for mid-life women, addressing disparities, and funding training and public outreach.
Would view it as an overdue public health investment but may seek larger funding and stronger equity guarantees.
Generally supportive but pragmatic: favors targeted federal investment in evidence generation, provider training, and public education, while wanting clear metrics, oversight, and attention to costs and program duplication.
Sees value if funds produce measurable improvements.
Cautiously skeptical: supports awareness and clinical training in principle but worries about federal overreach, new research categories, regulatory burdens, and ongoing spending.
Prefers state-led solutions, private-sector engagement, and tighter restrictions on federal role and cost growth.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, technocratic, and grant-focused measures with modest funding generally fare well, but enactment depends on appropriations and legislative priorities.
The bill has not accumulated any surfaced votes yet.
Left emphasizes health equity and research funding; right emphasizes federal spending and scope limits.
Narrow, technocratic, and grant-focused measures with modest funding generally fare well, but enactment depends on appropriations and legis…
Relative to its intended legislative type, this bill establishes a coherent statutory framework to expand federal activity on menopause care and mid-life women’s health by amending the Public Health Service Act, assigni…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.